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Use Rate and Outcome in Bilateral Internal Thoracic Artery Grafting:
Insights From a Systematic Review and Meta-Analysis
Mario Gaudino, MD; Faisal Bakaeen, MD; Umberto Benedetto, PhD; Mohamed Rahouma, MD; Antonino Di Franco, MD; Derrick Y. Tam, MD;
Mario Iannaccone, MD; Thomas A. Schwann, MD; Robert Habib, MD; Marc Ruel, MD; John D. Puskas, MD; Joseph Sabik, MD;
Leonard N. Girardi, MD; David P. Taggart, MD; Stephen E. Fremes, MD
Background-—This meta-analysis was designed to assess whether center experience affects the short- and long-term results and
the relative beneﬁts of bilateral internal thoracic artery grafting (BITA) for coronary artery bypass grafting.
Methods and Results-—MEDLINE and EMBASE were searched to identify all articles reporting the outcome of BITA in patients
undergoing coronary artery bypass grafting. The BITA center experience was gauged according to the percentage use of BITA in the
institutional overall coronary artery bypass grafting population (%BITA). The primary outcome was long-term all-cause mortality.
Secondary outcomes were operative mortality, perioperative myocardial infarction, perioperative stroke, deep sternal wound
infections (DSWIs), and major postoperative adverse event. The rates of the primary and secondary outcomes were calculated after
adjusting for %BITA. Primary and secondary outcomes were also compared between the BITA and the single internal thoracic artery
arms in the adjusted studies. Meta-regression was used to evaluate the effect of %BITA on the primary and secondary outcomes.
Thirty-four studies (27 894 patients undergoing BITA) were included. In the pooled analysis, the incidence rate for long-term
mortality was 2.83% (95% conﬁdence interval, 2.21%–3.61%). %BITA was signiﬁcantly and inversely associated with long-term
mortality and the rate of DSWI. In the pairwise comparison, %BITA was signiﬁcantly and inversely associated with the risk of long-
term mortality and DSWI in the group undergoing BITA.
Conclusions-—BITA series with higher %BITA report signiﬁcantly lower long-term mortality and DSWI rate as well as higher long-
term survival advantage and lower relative risk of DSWI in their BITA cohort. These ﬁndings suggest that a speciﬁc volume-outcome
relationship exists for BITA grafting. ( J Am Heart Assoc. 2018;7:e009361. DOI: 10.1161/JAHA.118.009361.)
Key Words: bilateral internal thoracic artery • CABG • coronary artery bypass graft • coronary artery bypass graft surgery
• experience • meta-analysis
T he relationship between center or operator experienceand outcome has extensively been described in
medicine and in surgery.1 The volume/outcome (V/O) effect
is particularly evident for technically complex procedures,
such as off-pump surgery or valve repair procedures.2 This
has resulted in recommendations for minimum center- and
surgeon-speciﬁc procedural volumes, as well as for special-
ized referral centers for highly complex cardiovascular and
cancer operations.1
Coronary artery bypass grafting surgery (CABG) is the most
common cardiac surgical procedure performed worldwide,
and a V/O effect for CABG has been extensively described.1,3
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The use of bilateral internal thoracic artery (BITA) increases
the technical complexity of the CABG operation.4 Previously
published studies on the V/O effect in CABG did not stratify
the results according to the type of technique used, although
in the great majority of the published series, BITA was used
only in a small minority of patients.
We hypothesized that, because of the more complex
nature of the procedure, a speciﬁc center experience to
outcome relationship exists for BITA grafting; therefore, we
aimed at investigating this by using a meta-analytic approach.
Methods
We conducted this systematic review and meta-analysis
following the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses statement.5 Table S1 illustrates the Meta-
Analysis of Observational Studies in Epidemiology guidelines
checklist. The data, analytic methods, and study materials will
not be made available to other researchers for purposes of
reproducing the results or replicating the procedure.
Search Strategy and Study Selection Criteria
OVID versions of MEDLINE and EMBASE were searched from
January 1972 to June 2017 to identify all articles reporting the
outcome of BITA in patients undergoing CABG.
The following keywords were used: “bilateral,” “double,”
“mammary,” “thoracic,” “artery,” “multiple,” “total,” “arterial,”
“revascularization,” and “coronary.” Their combinations were
searched using the term “AND.” All citations were screened
for study inclusion independently by 2 investigators (A.D.F
and M.G.). In case of disagreement, a consensus was reached.
In addition, the bibliography of all studies and meta-analyses
was searched to identify further publications (backward
snowballing).
Inclusion criteria for analysis were single-institution study,
sample size of at least 100 patients, and English language. We
excluded studies in which the percentage of BITA use of the
individual center (number of patients undergoing BITA/total
number of patients undergoing CABG in the center in the
study period=%BITA) could not be extracted. In case of
overlapping between studies or multiple publications from the
same center, only the publication with the largest sample size
was included.
The critical appraisal of the quality of included studies was
assessed using the Newcastle-Ottawa Scale for observational
studies.6 The highest possible score is 9 stars; <6 stars was
considered low quality, whereas ≥6 stars was considered high
quality (Table S2).
Data Abstraction
The following data were abstracted: study period, country,
institution, total sample size, number of patients undergoing
BITA, %BITA, annual CABG volume of the individual center
(total number of CABGs in the study/the study period), study
design, and follow-up duration. The following patient charac-
teristics were abstracted: age, female sex, diabetes mellitus,
left ventricular ejection fraction, number of grafts per patient,
number of internal thoracic artery grafts per patient, use of
internal thoracic artery sequentials, use of skeletonization
technique for BITA harvesting, and chronic obstructive
pulmonary disease.
For descriptive purposes, the studies were divided accord-
ing to quartiles of %BITA (boundaries for the quartiles were
17.1%, 29.2%, and 50.3%; the range of %BITA was 3.7%–64%).
In all the other analysis, %BITA was analyzed as a continuous
variable.
For the BITA versus single internal thoracic artery (SITA)
comparison, data were abstracted from the adjusted series
only (covariate adjusted or propensity matched). Crude event
rates, unadjusted and adjusted hazard ratios, 95% conﬁdence
intervals (CIs) for BITA and SITA, and log p-rank values were
abstracted. For the secondary outcomes, number of events
was extracted for each outcome.
Continuous variables were expressed as median (25th–
75th percentile) or as meanSD. Categorical variables were
reported as frequency (percentage).
Outcomes
The primary outcome was long-term all-cause mortality.
The secondary outcomes were operative mortality, periop-
erative myocardial infarction, perioperative stroke, deep
sternal wound infections (DSWIs), and major postoperative
adverse events, deﬁned as the composite of operative
mortality, perioperative myocardial infarction, perioperative
stroke, and DSWIs. Major postoperative adverse event was
derived only from studies that reported all 4 individual
outcome components.
Clinical Perspective
What Is New?
• Our analysis suggests the existence of a use rate to
outcome effect for bilateral internal thoracic artery grafting.
What Are the Clinical Implications?
• Our ﬁndings suggest the possibility that the creation of
specialized tertiary centers for coronary surgery, similar to
those that exist for aortic surgery and transplantation, may
improve the outcomes of bilateral internal thoracic artery
grafting.
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Analytic Plan and Statistical Analysis
In the pooled analyses, the incident rate or the pooled event
rates (PERs) of the primary and secondary outcomes in the
BITA series were calculated according to the %BITA.
In the pairwise comparisons including only the adjusted
studies, the relative risks of the primary and secondary
outcomes in the BITA series were calculated according to the
%BITA.
Pooled analysis
To account for the differential follow-up times of the primary
outcome in the various studies, an underlying Poisson process
with a constant event rate was assumed with a total number of
events observed within a treatment group of the total person-
time of follow-up for that treatment group calculated from study
follow-up. A log-link function was used to model the incidence
rate (IR), and a random effect was used. When the number of
events was not available from text or tables, the number of
events was derived from the unadjusted Kaplan-Meier curves
using GetData Graph Digitizer software 2.26 (http://getdata-
graph-digitizer.com) using a previously described method.7
For secondary outcomes, the PERs with 95% CIs were
calculated.
BITA versus SITA comparison
For the primary outcome, the generic inverse variance
(DerSimonian-Laird) method was used to pool the natural
logarithm of the IR ratio across studies to account for
potentially different follow-up durations between the studies.
We estimated the IR ratio through several means, depending
on the available study data. When hazard ratios were
provided, we took the natural logarithm of the hazard ratio;
the standard error was derived from the 95% CI or log-rank
P value.8 When event rates were not readily available, they
were extracted from Kaplan-Meier curves.7,9 The standard
error was estimated from the number of events in each arm.8
For secondary outcomes, individual and pooled odds ratio
(OR) with 95% CIs were used.
Meta-regression
In the pooled and pairwise analysis, univariable meta-
regression was used to explore the association between %
BITA and the primary and secondary outcomes.
A mixed-effects meta-regression model that contained
both study-speciﬁc covariates and random-effect components
was used to allow for the division of heterogeneity into an
explained (by the covariates) and an unexplained (the random-
effects) component.10 Each study was weighted by the
inverse of the variance of the estimate for that study, and
between-study variance was estimated with DerSimonian-
Laird estimator.
In both sets of analyses, a multivariable meta-regression
model was used to assess the association between %BITA
with the primary outcome while also adjusting for age, sex,
diabetes mellitus, and annual CABG hospital volume. A
separate multivariable meta-regression model, including %
BITA, sex, diabetes mellitus, annual CABG volume, and
skeletonization, was used to assess for the analysis of DSWI.
The Cochran Q statistic and the I2 test were used to assess
studies’ heterogeneity. For the primary outcome, if signiﬁcant
heterogeneity was detected (I2>75%), a leave-one-out sensi-
tivity analysis was performed to assess for single comparison
driven inference. Funnel plots and Egger regression test were
used to assess for potential publication bias. If publication
bias was suspected, visual assessment of the cumulative
forest plot and Duval and Tweedie’s trim and ﬁll methods were
used for further assessment.
A random-effect model (inverse variance method)11 was
used for all the analysis. Hypothesis testing for equivalence
was set at the 2-tailed 0.05 level.
All analyses were performed using R, version 3.3.3 (R
Project for Statistical Computing) using the following statis-
tical packages: “meta” and “metafor”12,13 within the RStudio,
0.99.489 (http://www.rstudio.com) and Comprehensive
Meta-Analysis V 3.0 (2006; Biostat, Inc, Englewood, NJ).
Results
Literature Search
The literature search identiﬁed 2899 potentially eligible
studies. Twenty-two additional articles were identiﬁed through
backward snowballing. The Preferred Reporting Items for
Systematic Reviews and Meta-Analyses ﬂow diagram is
reported in Figure 1.
Studies’ and Participants’ Characteristics
A total of 34 studies including 27 894 patients who had CABG
using BITA were included.14–47 Details of the individual
studies are shown in Tables 1 and 2 and Table S3. The
weighted mean follow-up time was 7.71.2 years. For the
pairwise comparison, 27 adjusted studies (12 propensity
matched) were included (75 334 patients; 19 290 BITAs and
56 044 SITAs). Eight studies (13 292 patients) were included
in the analysis of the composite major postoperative adverse
event.
The included studies were published from 1989 to 2016,
and the sample size ranged from 147 to 17 609.
Primary outcome
In the pooled analysis, the IR for long-term mortality in the
overall population was 2.83%/year (95% CI, 2.21%/year–
DOI: 10.1161/JAHA.118.009361 Journal of the American Heart Association 3
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3.61%/year; Table 3). The leave-one-out analysis is shown in
Figure S1, and the funnel plot and the cumulative analysis are
shown in Figure S2. %BITA was signiﬁcantly and inversely
associated with long-term mortality in the univariable meta-
regression (b=0.02, P=0.02; Figure 2A) and the multivari-
able meta-regression (b=0.03, P=0.04; Figure 2B).
In the pairwise comparison with SITA, the use of BITA was
associated with a signiﬁcantly lower long-term mortality (IR
ratio, 0.78; 95% CI, 0.72–0.84; Figure S3). %BITA was
signiﬁcantly and inversely associated with the IR ratio for
long-term mortality in both the univariable meta-regression
(b=0.006, P=0.01; Figure 3A) and the multivariable meta-
regression (b=0.008, P=0.03; Figure 3B).
Secondary outcomes
In the pooled analysis, the PER for operative mortality was
1.6% (95% CI, 1.2%–2.2%), the PER for myocardial infarction
was 1.6% (95% CI, 1.1%–2.4%), the PER for perioperative
stroke was 1.1% (95% CI, 0.9%–1.4%), the PER for DSWI was
2.2% (95% CI, 1.7%–2.7%), and the PER for major postoper-
ative adverse event was 5.7% (95% CI, 4.7%–6.8%) (Table 3). %
BITA was signiﬁcantly and inversely associated with DSWI,
according to the univariable and multivariable meta-regres-
sions (b=0.001 [P=0.006] and b=0.02 [P<0.001], respec-
tively; Table 3 and Figure 4). %BITA did not inﬂuence the other
secondary outcomes (Table 3 and Figure S4).
In the pairwise comparison with SITA, BITA use was
associated with a signiﬁcantly higher incidence of DSWI (OR,
1.58; 95% CI, 1.15–2.19) and a signiﬁcantly lower rate of
perioperative stroke (OR, 0.76; 95% CI, 0.61–0.94). %BITA
was signiﬁcantly and inversely associated with the OR for
DSWI by univariable and multivariable meta-regressions
(b=0.020 [P=0.02] and b=0.03 [P=0.005], respectively;
Figure 5).
No signiﬁcant differences were found for the other
secondary outcomes (Figure S5).
Discussion
An inverse relationship between hospital volume and clinical
outcome has been described extensively in surgery.1 Some
data suggest that the V/O relationship can be more evident
for more complex procedures, such as off-pump CABG, or
higher-risk patients.2
The V/O effect in CABG has been the focus of a large
amount of research. Despite controversy related to the
methodological quality of the sources used in the published
studies and the lack of a clear-cut explanation, it is usually
accepted that hospitals that perform a high annual volume of
CABG and have more experience with the procedure have
better outcomes than hospitals that perform a smaller
number of procedures.1–3 The use of BITA during CABG adds
technical complexity to the operation. In a survey of all UK
consultant cardiac surgeons, the perceived increased techni-
cal difﬁculty and need of a learning curve were the most
frequent reason to explain the low adoption rate of BITA.4
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses ﬂow chart. BITA indicates
bilateral internal thoracic artery; SITA, single internal thoracic artery.
DOI: 10.1161/JAHA.118.009361 Journal of the American Heart Association 4
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Table 1. Overview of the Included Studies: 1
Study Year Center Study Period Setting Type of Study
Benedetto et al14 2014 Harefield Hospital (London, UK) 2001–2013 First-time isolated CABG Retrospective
Buxton et al15 1998 Austin and Repatriation Medical
Center, University of
Melbourne (Melbourne,
Victoria, Australia)
1985–1995 Isolated primary CABG Retrospective
Calafiore et al16 2004 University Hospital (Torino, Italy)
and “G D’Annunzio” University
(Chieti, Italy)
1986–1999 Patients <75 y who
undergo first
myocardial
revascularization
Retrospective
Carrier et al17 2009 Montreal Heart Institute
(Montreal, Quebec, Canada)
1995–2007 Isolated primary CABG Retrospective
Danzer et al18 2001 University Hospital (Geneva,
Switzerland)
1983–1989 Isolated primary CABG Retrospective
Dewar et al19 1995 Vancouver Hospital and Health
Sciences Centre, University of
British Columbia (Vancouver,
British Columbia, Canada)
1984–1992 Isolated primary CABG
(93.2% were having a
first operative
procedure)
Retrospective
Elmistekawy et al20 2012 Ottawa Heart Institute (Ottawa,
Ontario, Canada)
1997–2007 Isolated CABG in
patients ≥65 y
Retrospective
Endo et al21 2001 Tokyo Women’s Medical
University (Tokyo, Japan)
1985–1998 Elective isolated primary
CABG (including
children with Kawasaki
disease)
Retrospective
Gansera et al22 2001 Klinikum Bogenhausen (Munich,
Germany)
1996–1999 Isolated CABG Retrospective
Gansera et al23 2004 Klinikum Bogenhausen (Munich,
Germany)
1997–1999 Elective isolated primary
CABG
Retrospective
Grau et al24 2015 The Valley Columbia Heart
Center, Columbia University
College of Physicians and
Surgeons (Ridgewood, NJ)
1994–2013 Isolated CABG Retrospective
Hirotani et al25 2003 Tokyo Saiseikai Central Hospital
(Minato-Ku, Tokyo, Japan)
1991–2003 Isolated primary CABG in
diabetic patients
Retrospective
Ioannidis et al26 2001 St Luke’s–Roosevelt Hospital
Center (New York, NY)
1993–1996 Isolated CABG Prospective
Itoh et al27 2016 Saitama Medical Center, Jichi
Medical University (Saitama,
Japan)
1990–2014 Isolated CABG in elderly
patients (≥75 y)
Retrospective
Johnson et al28 1989 Milwaukee Heart Surgery
Associates, SC, and St Mary’s
Hospital (Milwaukee, WI)
1972–1986 Isolated CABG (including
redo)
Retrospective
Jones et al29 2000 Baylor College of Medicine and
Veterans Affairs Medical
Center (Houston, TX)
1986–1996 Isolated primary CABG in
patients >65 y
Retrospective
Joo et al30 2012 Yonsei Cardiovascular Hospital
(Seoul, Republic of Korea)
2000–2009 Isolated OPCAB Retrospective
Kelly et al31 2012 Queen Elizabeth II Health
Sciences Center (Halifax, Nova
Scotia, Canada)
1995–2009 Isolated primary CABG Retrospective
Kinoshita et al32 2015 Shiga University of Medical
Science (Otsu, Japan)
2002–2014 Isolated CABG (patients
stratified by GFR)
Retrospective
Continued
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In the recently published ART (Arterial Revascularization
Trial), only 83.6% of the patients randomized to BITA received
the assigned treatment (versus 96.1% in the conventional
CABG group).48 This high crossover rate in the BITA series is a
testament to higher technical complexity of the operation, and
it is even more meaningful if one considers that only expert
BITA surgeons were allowed to participate in ART. However, it
also raises the possibility that the BITA surgeons were not all
equally experienced in BITA grafting because the crossover
rate varied from 0% to 42.9% on a center level and from 0% to
100% for the 168 participating surgeons, suggesting the need
for appropriate and documented experience for participation
in trials involving complex technical procedures. Thus, as
complexity of the coronary surgery increases with the addition
of a BITA grafting strategy, institution experience with BITA
may play an ever-increasing role on outcomes. However, to
date, this subject has not been investigated in detail.
Our data suggest that a relationship between the rate of
BITA use at the center level and the clinical results exists at
least for the 2 most important outcomes associated with BITA
grafting: long-term survival and incidence of DSWI. In our
analysis, long-term mortality was signiﬁcantly and inversely
associated with %BITA, with better survival reported by
centers with high %BITA. In the pairwise comparison with
SITA, the long-term survival beneﬁt associated with the use of
BITA was signiﬁcantly associated with %BITA, with centers
with high %BITA reporting a signiﬁcantly larger survival
advantage for patients undergoing BITA. The effect of %BITA
on long-term mortality remained signiﬁcant even when
entering the annual hospital volume as a covariate in the
Table 1. Continued
Study Year Center Study Period Setting Type of Study
Konstanty et al33 2012 Collegium Medicum Jagiellonian
University (Krakow, Poland)
2006–2008 Isolated primary CABG in
diabetic patients
Retrospective
Kurlansky et al34 2010 Florida Heart Research Institute
(Miami, FL)
1972–1994 Isolated CABG Retrospective
Locker et al35 2012 Mayo Clinic (Rochester, MN) 1993–2009 Isolated primary CABG Retrospective
Lytle et al36 2004 The Cleveland Clinic Foundation
(Cleveland, OH)
1971–1989 Isolated primary CABG Retrospective
Medalion et al37 2015 Tel Aviv Sourasky Medical
Center (Tel Aviv, Israel)
1996–2008 Isolated CABG in
patients ≥70 y
Retrospective
Mohammadi et al38 2014 Quebec Heart and Lung Institute
(Quebec City, Quebec, Canada)
1991–2011 Isolated primary CABG in
patients with EF ≤40%
Retrospective
Naunheim et al39 1992 St Louis University Medical
Center (St Louis, MO)
1972–1975 Isolated CABG Retrospective
Navia et al40 2016 Instituto Cardiovascular de
Buenos Aires (Buenos Aires,
Argentina)
1996–2014 Isolated urgent or
elective CABG (BITA
grafting in a T
configuration)
Retrospective
Parsa et al41 2013 Duke University Medical Center
(Durham, NC)
1984–2009 Isolated CABG Prospective
Pettinari et al42 2014 Ziekenhuis Oost Limburg (Genk,
Belgium) and University
Hospitals Leuven (Leuven,
Belgium)
1972–2006 CABG in elderly patients
(≥70 y)
Retrospective
Pusca et al43 2008 Emory University School of
Medicine (Atlanta, GA)
1997–2006 Isolated CABG Retrospective
Rosenblum et al44 2016 Emory University School of
Medicine (Atlanta, GA)
2003–2013 Primary isolated CABG Retrospective
Stevens et al45 2004 Montreal Heart Institute
(Montreal, Quebec, Canada)
1985–1995 Isolated primary CABG
with ≥3 grafts
Retrospective
Tarelli et al46 2001 Varese Hospital (Varese, Italy) 1988–1990 Isolated CABG Retrospective
Walkes et al47 2002 Baylor College of Medicine and
Veterans Affairs Medical center
(Houston, TX)
1990–2000 Isolated CABG Retrospective
BITA indicates bilateral internal thoracic artery; CABG, coronary artery bypass grafting; EF, ejection fraction; GFR, glomerular ﬁltration rate; OPCAB, off-pump coronary artery bypass.
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meta-regression model, suggesting the existence of an
“experience effect” speciﬁc for BITA grafting and independent
from the V/O relationship for standard CABG.
The rate of DSWI and the increase in the risk of DSWI in
the BITA group were also signiﬁcantly and inversely associ-
ated with %BITA. Centers with high %BITA reported a lower
incidence of DSWI in the BITA series and a lower relative risk
of DSWI in the BITA group compared with the SITA series.
Furthermore, the incidence and risk of the short-term
outcomes, such as operative mortality, perioperative myocar-
dial infarction, and perioperative stroke, were not inﬂuenced
by the %BITA.
Taken together, our ﬁndings seem to suggest that the
reasons for the reported difference in outcomes between
Table 2. Overview of the Included Studies: 2
Study
Overall
Population, n BITA, n Mean/Median Follow-Up, y
Completeness
of Follow-Up, %
Benedetto et al14 4195 750 4.83.2 (PSM sample) 100
Buxton et al15 2826 1269 4.3 95.9
Calafiore et al16 1602 1026 BITA: 7.15.0 100
Carrier et al17 6655 1235 10 99
Danzer et al18 521 382 10 97.5
Dewar et al19 1142 377 4 NR
Elmistekawy et al20 3940 359 NR NR
Endo et al21 1131 443 6.2 99.3
Gansera et al (2001)22 3671 1487 NR NR
Gansera et al (2004)23 1378 716 5.3 NR
Grau et al24 6666 1544 BITA: 10.95 100
Hirotani et al25 303 179 NR 95
Ioannidis et al26 1697 867 NR NR
Itoh et al27 400 107 9.05.8 95.6
Johnson et al28 2014 576 NR 100
Jones et al29 510 172 5.03.1 100
Joo et al30 1749 392 BITA: 6.92.1 98.1
Kelly et al31 7633 1079 BITA: 5.4 NR
Kinoshita et al32 1203 750 PSM BITA: 5.63.3 99
Konstanty et al33 147 38 NR NR
Kurlansky et al34 4584 2215 BITA: 12.7 BITA: 96.7
Locker et al35 8295 860 7.64.6 100
Lytle et al36 10 124 2001 BITA: 16.22.4 100
Medalion et al37 1627 1045 8.24.5 98
Mohammadi et al38 1795 129 PSM BITA: 8.65.1 92.7
Naunheim et al39 365 100 NR 96.5
Navia et al40 2486 2098 Median, 5.5 (IQR, 2.6–8.8) 95
Parsa et al41 17 609 728 NR 100
Pettinari et al42 3496 1328 3.1 100
Pusca et al43 10 811 599 NR NR
Rosenblum et al44 8254 873 Median, 2.8 (IQR, 1.1–4.9) 100
Stevens et al45 4382 1835 BITA: 82 98
Tarelli et al46 300 150 BITA: 9.22.8 100
Walkes et al47 1069 158 NR NR
BITA indicates bilateral internal thoracic artery; IQR, interquartile range; NR, not reported; PSM, propensity score matched.
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centers at high and low %BITA are not strictly technical,
because outcomes that are heavily inﬂuenced by technical
factors, such as perioperative myocardial infarction, stroke,
and operative mortality, were not signiﬁcantly associated
with %BITA. One explanation for our results may be better
patient selection and grafting strategy in centers at high %
BITA. It is possible that more experienced centers
were more proﬁcient in selecting appropriate patients who
Table 3. Outcomes Summary
Quartile No. of Studies Patients PER/IR, % 95% CI, %
Heterogeneity, I2,
P Value s2
Long-term mortality
First quartile 5 3377 3.68 2.18–6.21 98.40, P<0.001 0.336
Second quartile 8 4579 3.2 2.35–4.37 96.52, P<0.001 0.185
Third quartile 8 7712 4.45 2.73–7.26 99.40, P<0.001 0.485
Fourth quartile 7 3712 1.04 0.50–2.19 97.60, P<0.001 0.924
Overall 28 19 380 2.83 2.21–3.61 98.90, P<0.001 0.412
Perioperative MI
First quartile 5 2598 1.2 0.49–2.91 78.972, P=0.001 0.778
Second quartile 4 1530 2.121 1.02–4.36 60.970, P=0.053 0.329
Third quartile 3 3954 2.454 0.97–6.08 93.294, P<0.001 0.643
Fourth quartile 6 5141 1.321 0.72–2.42 81.853, P<0.001 0.432
Overall 18 2598 1.632 1.12–2.38 86.706, P<0.001 0.546
Stroke
First quartile 5 2598 1.045 0.64–1.70 27.658, P=237 0.086
Second quartile 6 2387 1.27 0.72–2.22 44.368, P=110 0.208
Third quartile 4 4846 1.101 0.84–1.44 0.000, P=0.530 0
Fourth quartile 7 5891 1.426 0.75–2.70 87.346, P<0.001 0.636
Overall 22 15 722 1.142 0.93–1.40 74.605, P<0.001 0.36
DSWI
First quartile 5 3197 2.805 2.17–3.61 0.000, P=0.551 0
Second quartile 3 2387 3.304 1.38–7.72 39.075, P=0.194 0.5
Third quartile 5 8981 1.525 1.18–1.97 30.744, P=0.217 0.164
Fourth quartile 5 6037 1.675 1.28–2.19 0.000, P=0.735 0
Overall 18 20 602 1.968 1.70–2.28 46.688, P=0.016 0.281
Perioperative mortality
First quartile 3 2385 1.328 0.45–3.87 88.184, P<0.001 0.822
Second quartile 6 3158 1.562 0.65–3.72 82.822, P<0.001 0.877
Third quartile 5 5398 1.442 0.89–2.32 74.551, P=0.003 0.213
Fourth quartile 5 4845 1.923 1.10–3.34 84.795, P<0.001 0.342
Overall 19 15 786 1.591 1.15–2.19 80.805, P<0.001 0.352
MAE
First quartile 2 1232 7.725 3.30–17.03 93.918, P<0.001 0.393
Second quartile 2 966 7.122 1.44–28.62 91.912, P<0.001 1.314
Third quartile 2 1739 5.474 4.50–6.65 0.000, P=0.498 0
Fourth quartile 3 3525 6.632 3.67–11.70 94.552, P<0.001 0.282
Overall 9 7462 5.682 4.74–6.79 89.869, P<0.001 0.204
IR was used for long-term mortality. CI indicates conﬁdence interval; DSWI, deep sternal wound infection; IR, incidence rate; MAE, major postoperative adverse event (operative
mortality+MI+stroke+DSWI); MI, myocardial infarction; PER, pooled event rate.
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would beneﬁt from BITA grafting and the use of the arterial
grafts.
It is notable that 67% of the studies in the highest quartile
of %BITA versus 38% in the lowest quartile used BITA
sequentials (P=0.03). It has been shown that an increase in
the number of BITA anastomoses is associated with better
clinical outcome.49
For DSWI, the adoption of the skeletonized technique for
harvesting was similar between high and low BITA users
(42.9% in the ﬁrst quartile and 57.1% in the fourth quartile;
P=0.56), and the association between the OR for DSWI and %
BITA was conﬁrmed, even in the multivariable meta-regression
model after adjusting for skeletonization. These results
suggest that BITA skeletonization alone is not the explanation
for the reported difference in DWSI.
This analysis must be interpreted in the context of some
limitations. We used %BITA as opposed to BITA volume as a
marker of experience with BITA because we believe that the
Figure 2. The effect of the percentage of bilateral internal thoracic artery (BITA) use on the long-term mortality (expressed as incidence rate)
according to the univariable (A) and multivariable (B) meta-regressions. DM indicates diabetes mellitus; totCABG, total coronary artery bypass
grafting.
Figure 3. The effect of the percentage of bilateral internal thoracic artery (BITA) use on the long-term mortality (expressed as incident rate
ratio) according to the univariable (A) and multivariable (B) meta-regressions. CABG indicates coronary artery bypass grafting; DM, diabetes
mellitus.
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rate of use is a stronger surrogate measure of familiarity,
comfort, and skill in the operation than the absolute volume of
procedures performed. However, this assumption is based on
the authors’ opinion, and has never been objectively validated.
We did not capture individual surgeon’s experience, which
may be more important than center’s experience. Also, the
included studies used different surgical protocols and deﬁni-
tion of outcomes and were in different stages of their BITA
learning curve, leading to heterogeneity in the analyzed data.
Most important, an unavoidable publication bias exists,
because all centers were in some way experienced in the
use of BITA (although at different levels). Our analysis
probably does not capture the results of inexperienced
centers or beginners in BITA grafting who are unlikely to
publish their results. In addition, meta-regressions can only be
used to assess association and do not infer causality.
Nonetheless, despite these limitations, the reproducibility of
our results, on the basis of multiple different statistical
approaches, supports the robustness of our reported ﬁndings.
In conclusion, our analysis suggests the existence of a
use rate to outcome effect for BITA grafting. In our study,
centers that used BITA more frequently reported a reduced
risk of sternal complications and achieved better long-term
survival compared with SITA. Our ﬁndings suggest the
possibility that the creation of specialized tertiary centers
for coronary surgery, similar to those that exist for aortic
surgery and transplantation, may improve the outcomes of
BITA grafting.
Figure 5. The effect of the percentage of bilateral internal thoracic artery (BITA) use on the odds ratio of deep sternal wound infection by
univariable (A) and multivariable (B) meta-regressions. CABG indicates coronary artery bypass grafting; DM, diabetes mellitus.
Figure 4. The effect of the percentage of bilateral internal thoracic artery (BITA) use on the pooled event rate of deep sternal wound infection
by univariable (A) and multivariable (B) meta-regressions. CABG indicates coronary artery bypass grafting; DM, diabetes mellitus.
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Table S1. MOOSE Checklist for Meta-analyses of Observational Studies. 
Item No Recommendation Page No. 
Reporting of background should include 
1 Problem definition 3 
2 Hypothesis statement 3 
3 Description of study outcome(s) 5 
4 Type of exposure or intervention used 4 
5 Type of study designs used 4 
6 Study population 4 
Reporting of search strategy should include 
7 Qualifications of searchers (e.g., librarians and investigators) 4 
8 Search strategy, including time period included in the synthesis and 
key words 
4 
9 Effort to include all available studies, including contact with authors 4 
10 Databases and registries searched 4 
11 Search software used, name and version, including special features 
used (e.g., explosion) 
4 
12 Use of hand searching (e.g., reference lists of obtained articles) 4 
13 List of citations located and those excluded, including justification 4 
14 Method of addressing articles published in languages other than 
English 
4 
15 Method of handling abstracts and unpublished studies 4 
16 Description of any contact with authors 4 
Reporting of methods should include 
17 Description of relevance or appropriateness of studies assembled 
for assessing the hypothesis to be tested 
4 
18 Rationale for the selection and coding of data (e.g., sound clinical 
principles or convenience) 
4 
19 Documentation of how data were classified and coded (e.g., 
multiple raters, blinding and interrater reliability) 
4 
20 Assessment of confounding (e.g., comparability of cases and 
controls in studies where appropriate) 
4 
21 Assessment of study quality, including blinding of quality assessors, 
stratification or regression on possible predictors of study results 
4 
22 Assessment of heterogeneity 7 
23 Description of statistical methods (e.g., complete description of 
fixed or random effects models, justification of whether the chosen 
models account for predictors of study results, dose-response 
models, or cumulative meta-analysis) in sufficient detail to be 
replicated 
5-8 
D
ow
nloaded from
 http://ahajournals.org by on January 25, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data derived from Stroup DF, Berlin JA, Morton SC, et al, for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of Observational Studies in Epidemiology. A 
Proposal for Reporting. JAMA. 2000;283:2008-2012. Transcribed from the original paper within the NEUROSURGERY® Editorial Office, Atlanta, GA, United States. August 2012. 
  
24 Provision of appropriate tables and graphics See tables and 
figures 
Reporting of results should include 
25 Graphic summarizing individual study estimates and overall 
estimate 
See figures 
26 Table giving descriptive information for each study included See tables 
27 Results of sensitivity testing (e.g., subgroup analysis) 9-10 
28 Indication of statistical uncertainty of findings 9-10 
29 Quantitative assessment of bias (e.g., publication bias) 9-10 
30 Justification for exclusion (e.g., exclusion of non-English language 
citations) 
Figure 1 
31 Assessment of quality of included studies Suppl. Table 2 
Reporting of conclusions should include 
32 Consideration of alternative explanations for observed results 13 
33 Generalization of the conclusions (i.e., appropriate for the data 
presented and within the domain of the literature review) 
11-13 
34 Guidelines for future research 13 
35 Disclosure of funding source 14 
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Table S2. Summary of critical appraisal of included studies using the Newcastle-Ottawa Scale for Cohort Studies. 
 
Study Selection Comparability Outcome/Exposure 
Benedetto1 **** ** *** 
Buxton2 **** ** *** 
Calafiore3 **** ** *** 
Carrier4 **** ** *** 
Danzer5 **** ** ** 
Dewar6 **** ** * 
Elmistekawy7 **** ** * 
Endo8 **** ** *** 
Gansera 20019 **** ** * 
Gansera 200410 **** ** ** 
Grau11 **** ** *** 
Hirotani12 **** * ** 
Ioannidis13 **** ** * 
Itoh14 **** ** *** 
Johnson15 **** ** *** 
Jones16 **** * *** 
Joo17 **** ** *** 
Kelly18 **** ** ** 
Kinoshita19 **** ** *** 
Konstanty20 **** ** * 
Kurlansky21 **** ** *** 
Locker22 **** ** *** 
Lytle23 **** ** *** 
Medalion24 **** ** *** 
Mohammadi25 **** ** *** 
Naunheim26 **** ** *** 
Navia27 **** ** *** 
Parsa28 **** ** *** 
Pettinari29 **** ** *** 
Pusca30 **** ** * 
Rosenblum31 **** ** *** 
Stevens32 **** ** *** 
Tarelli33 **** ** *** 
Walkes34 **** ** * 
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Selection 
 
1) Representativeness of intervention cohort - a) truly representative of the average in the community, treated with CSF 
drainage during/after thoracic/thoracoabdominal surgery*; b) somewhat representative of the average, treated with CSF 
drainage during/after thoracic/thoracoabdominal surgery*; c) only selected group of users; d) no description of the 
derivation of the cohort. 
2) Selection of non-intervention cohort – a) drawn from same community as intervention cohort*; b) drawn from a different 
source; c) no description of the derivation of the non-exposed cohort. 
3) Ascertainment of exposure - a) secure record*; b) structured interview*; c) written self-report; d) no description. 
4) Demonstration that outcome of interest was not present at start of study - a) yes*; b) no. 
 
Comparability 
 
1) Comparability of cohorts on the basis of the design or analysis - a) study controls for age, and gender*; b) study controls 
for any additional factor*. 
 
Outcome 
 
1) Assessment of outcome - a) independent blind assessment*; b) record linkage*; c) self-report; d) no description. 
2) Was follow-up long enough for outcomes to occur - a) yes*; b) no 
3) Adequacy of follow up of cohorts - a) complete follow up*; b) subjects lost to follow up unlikely to introduce bias - < 20 % 
lost follow up*; c) follow up rate < 80% and no description of those lost; d) no statement. 
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Table S3. Risk factor distribution in the populations of the studies included in the primary analysis. 
Study  Age (y) Mean±SD Female (%) DM (%) EF COPD (%) Mean #of grafts/anastomosis 
per patient 
Use of 
sequential 
grafting 
Use of 
skeletonized 
ITAs 
Mean #of CABG 
performed per 
year 
Benedetto1  NR (Ranges) 10.8 15.9 EF<50% in 13.2% 7.7 2.88 (BITA) vs 2.74 (SITA) NO YES 347,17 
Buxton2  58.6 ± 9 10.6 6.8 EF<50% in 4.9% NR 3.38±0.80 (BITA) vs 3.07±0.89 
(SITA) 
YES NO 258,87 
Calafiore3  60.7 ± 8.3 19.3 24.2 59.4 ± 13.1 2.8 2.8±0.9 (BITA) vs 2.8±0.9 
(SITA)* 
YES YES 120,91 
Carrier4  61 ± 9 16 21 NR NR NR YES NO 515,23 
Danzer5  59.8 ± 8.8 12 13.6 EF<40% in 13.6 NR NR NO NO 115,78 
Dewar6  NR 15.4 17.7 NR NR 3.9 (BITA) vs 3.57 (SITA)  NO NR 128,07 
Elmistekawy7  71.2 ± 5.0 23.4 32.7 NR NR 2.93±0.63 (BITA) vs 2.86±0.78 
(SITA) 
NO YES 411,13 
Endo8  61 (6-85) 9.7 42.9 54% (median) NR 2.85 (BITA) vs 2.66 (SITA) YES YES 87,56 
Gansera 20019  64.4± 9.4 18.6 28.1 62.1 ± 14.6 NR 3.63±0.9 (BITA) vs 3.14±0.9 
(SITA) 
NO NO 937,28 
Gansera 200410  69.2 (42.7-88.6) 16 26 NR NR 3.58 (BITA) vs 3.13 (SITA) NO NO 533,42 
Grau11  60 ± 9 10.4 11 51 ± 11 5.1 3.7±1 (BITA off-pump), 3.5±1 
(BITA on-pump), 3.5±1 (SITA 
off-pump), 3.4±1 (SITA on-
pump)* 
Surgical 
details NR 
NR 334,69 
Hirotani12  64.8 ± 7.8 23 100 48.2 ± 15.1 NR 3.5±1.0 (BITA) vs 2.8±1.0 (SITA) YES NO 25,79 
Ioannidis13  62.0±10.3 22.6 25.6 46.5 ± 13.7 13 NR Surgical 
details NR 
NR 433,28 
Itoh14  77.6 ± 2.5 23.4 37.4 EF<40% in 10.3% NR NR NO YES 16,11 
Johnson15  NR NR NR NR NR NR Surgical 
details NR 
NR 145,59 
Jones16  69.2 19.2 NR EF<50% in 38.9% NR 3.34 (BITA) vs 2.90 (SITA) NO NR 51,00 
Joo17  60.4 ± 9.1 39.8 38.3 57 ± 11% 7.4 3.22±0.78 (SITA) vs 3.32±0.69 
(BITA)* 
YES semi-
skeletonized 
method used 
176,37 
Kelly18  58.4 ± 10.0 18 26 EF<40% in 7% 11 3.2±1.0 (BITA) vs 3.2±0.9 (SITA) YES NO 511,71 
Kinoshita19  69 ± 8 16 61 52 ± 14% 19 NR YES YES 96,89 
Konstanty20  62 ± 8.3 34 60.5 51.6 ± 8 7.8 2.60 ± 0.59 (BITA) vs 2.57±0.61 
(SITA) 
NO NO 58,80 
Kurlansky21  62.9 ± 10.0 14.9 20.8 EF<30% in 3.9% NR Total #of grafts: 3.3 (BITA) vs 
3.1 (SITA)  
YES YES 206,02 
Locker22  NR NR NR NR NR NR YES YES 490,34 
Lytle23  57.5 ± 8.1 12 12 NR NR NR Surgical 
details NR 
NR 535,19 
Medalion24  NR (ranges) 27 32.2 EF≤30% in 8.2% 5.5 NR YES YES 125,96 
Mohammadi25  54.6 ± 9.5 9.3 14 EF≤30% in 30.2% 12.4 3.7±1.0 (BITA) vs 3.6±1.0 (SITA) NO NO 87,56 
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Naunheim26  49.6 ± 7.9 17 4 NR NR 2.4±0.5 (BITA) vs 2.3±0.8 (SITA) NO NO 93,19 
Navia27  63.7 ± 9.1 9.8 25.9 NR 4.2 NR YES YES 142,06 
Parsa28  59 (median) 19.8 14.7 51% (median) 3.9 Median #of grafts per patients: 
3 (BITA) vs 3 (SITA) 
YES NR 679,45 
Pettinari29  73.2 ± 2.8 26.1 12.6 44.3 ± 32.2 16.3 3.14±0.92 (BITA) vs 3.07±0.93 
(SITA)* 
NO semi-
skeletonized 
method used 
100,12 
Pusca30  58.0 ± 0.34 17.4 25.2 51.6± 11.4 12 3.67 (BITA) vs 3.45 (SITA) NO YES 1148,07 
Rosenblum31  59.0 ± 10.1 15.5 27.6 52.2 ± 11.0 1.8 3.7±1.0 (BITA) vs 3.3±0.9 (SITA) NO NO 832,34 
Stevens32  57 ± 9 12 12 NR 4 3.4±0.6 (BITA) vs 3.2±0.5 (SITA) NO NO 434,58 
Tarelli33  56.5 ± 8.2 7.3 11.3 57.2 ± 13.6 NR 3.0±0.6 (BITA) vs 2.9±0.5 (SITA) NO NO 102,86 
Walkes34  57.0 ± 9.4 1.9 29.5 NR 24.1 2.99±0.88 (BITA) vs 2.90±0.91 
(SITA) 
NO NO 107,80 
 
*data available for matched populations only. COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; EF, ejection fraction; NR, not reported; SD, standard deviation.  
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Figure S1. The “Leave-one-out” analysis for the primary outcome. 
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Figure S2. The pooled analysis for long term mortality: A) Funnel plot with trim and fill method and B) Cumulative meta-analysis. 
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Figure S3. The pairwise comparison for long term mortality among the adjusted studies using the incident rate ratio. 
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Figure S4. The effect of the percentage of BITA use on the pooled event rate of A) peri-operative myocardial infarction, B) peri-operative stroke, C) 
major postoperative adverse events (MAE), D) operative mortality. 
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Figure S5. The effect of the percentage of BITA use on the odds ratio of A) peri-operative myocardial infarction, B) peri-operative stroke, C) major 
postoperative adverse events (MAE), D) operative mortality. 
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